NIH provided the University of Texas Health’s Human Genetics Center funds to research how genomic variation affects individual and population health. U.S. prosecutors received a tip alleging the center misused NIH funds by placing a $1.2 million order for a large amount of genetic sequencing material from biotechnology company Illumina just before the grant ended.
The tip accused the University of Texas Health of then stopping the shipment of the goods and having Illumina credit the center for the material. The Genetics Center then used the credit to purchase goods and services after the grant ended, the Justice Department claims.
The tip was substantiated by a two-year investigation, according to the department.
More articles on legal and regulatory issues:
Ex-CEO gets 46 months in prison for defrauding Florida hospital
New York hospital let woman end life support for stranger, lawsuit claims
10 employees hit NewYork-Presbyterian with $15M discrimination suit
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.